Skip to content

Research of the effect and mechanism of Marine active peptide intervention on nutrition and immunity level of tumor patients

Research of the effect and mechanism of Marine active peptide intervention on nutrition and immunity level of tumor patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041637
Enrollment
Unknown
Registered
2021-01-01
Start date
2021-01-04
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor of digestive tract

Interventions

control group:Regular nutrition education + independent eating
Nutrition intervention group:On the basis of the control group + routine nutritional intervention (whole-protein enteral nutritional powder + short peptide enteral nutritional powder)
Nutrition intervention group 2:On the basis of the control group, + routine nutritional intervention (whole-protein enteral nutrition powder + short peptide enteral nutrition powder) + Marine active p

Sponsors

Shenzhen Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed malignant tumor; 2. Version 7 AJCC/UICC stage III a stage IV; 3. Aged >= 18 years; 4. PS (per - formance status) score 2 or less; 5. No contraindications of chemoradiotherapy; 6. After chemoradiotherapy appetite is fair, can be through the mouth into the eater.

Exclusion criteria

Exclusion criteria: 1. Poor compliance, not long-term adherence; 2. Unstable vital signs; 3. Patients with severe hepatic and renal insufficiency; 4. Persons with allergic constitution; 5. A history of acute or chronic infectious disease, trauma, or surgery in the month preceding the study; 6. Patients taking part in other studies; 7. The researchers concluded that other causes did not apply to researchers: acute diarrhea, etc..

Design outcomes

Primary

MeasureTime frame
body weight;Muscle mass;Fat mass;Liver function;Kidney function;Intestinal barrier function;Semi-quantitative analysis of intestinal flora;

Countries

China

Contacts

Public ContactZhu Cuifeng

Shenzhen Hospital of Southern Medical University

1794371266@qq.com+86 13510331416

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026